A urinary DNA methylation test showed potential for detecting high-grade or invasive bladder cancer, according to results of ...

Sacral neuromodulation, in which electrical pulses from an implanted device help control the bladder, was found to ease ...

The most common reason for cisplatin-ineligibility is renal function impairment. Up to 40% of patients with bladder cancer have renal impairment, defined as a creatinine clearance ≤60 ml/min ...

A modified herpes virus that targets spinal cord nerve cells to treat neurogenic bladder in people with spinal cord injury is underway in a first-in-human clinical trial by UTHealth Houston at TIRR ...

Advanced transitional-cell carcinoma of the bladder is the most common cancer ... Nevertheless, 40–50% of patients have impaired renal function that precludes the use of cisplatin.